Employees: 12 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2011-06-30 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ANCENIS-SAINT-GEREON (44150), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE ESPACE 23 : revenue, balance sheet and financial ratios
PHARMACIE ESPACE 23 is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ANCENIS-SAINT-GEREON (44150),
this company of category PME
shows in 2024 a net income positive of 345 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE ESPACE 23 (SIREN 534080270)
Indicator
2024
2023
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
344 601 €
340 080 €
155 511 €
346 563 €
325 908 €
316 163 €
273 042 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE ESPACE 23 generates positive net income of 345 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 273 k€ -> 345 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
344 601 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 47%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
47.428%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.253%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2023
2024
Debt ratio
227.628
166.485
125.528
92.908
92.169
52.27
47.428
Financial autonomy
27.632
33.804
40.13
46.0
45.543
59.008
61.253
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
47.432024
2020
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Good
In 2024, the debt ratio of PHARMACIE ESPACE 23 (47.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.25%2024
2020
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Good+10 pts over 3 years
In 2024, the financial autonomy of PHARMACIE ESPACE 23 (61.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 228.39. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2023
2024
Liquidity ratio
151.209
145.382
155.082
130.066
172.356
213.926
228.394
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
228.392024
2020
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good+20 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE ESPACE 23 (228.39) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE ESPACE 23 in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE ESPACE 23 is estimated at
4 810 884 €
(range 3 350 224€ - 7 197 358€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3350k€4810k€7197k€
4 810 884 €Range: 3 350 224€ - 7 197 358€
NAF 5 année 2024
Valuation method used
Net Income Multiple
344 601 €
×
14.0x
=4 810 885 €
Range: 3 350 224€ - 7 197 359€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE ESPACE 23 with other companies in the same sector:
Frequently asked questions about PHARMACIE ESPACE 23
What is the revenue of PHARMACIE ESPACE 23 ?
The revenue of PHARMACIE ESPACE 23 is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE ESPACE 23 profitable?
Yes, PHARMACIE ESPACE 23 generated a net profit of 345 k€ in 2024.
Where is the headquarters of PHARMACIE ESPACE 23 ?
The headquarters of PHARMACIE ESPACE 23 is located in ANCENIS-SAINT-GEREON (44150), in the department Loire-Atlantique.
Where to find the tax return of PHARMACIE ESPACE 23 ?
The tax return of PHARMACIE ESPACE 23 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE ESPACE 23 operate?
PHARMACIE ESPACE 23 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart